Skip to main content
Clinical Trials/NCT04385901
NCT04385901
Completed
Not Applicable

Long Term Functional Outcomes of COVID-19 Patients Treated by Rehabilitation Services viaTelehealth

University of Missouri-Columbia1 site in 1 country26 target enrollmentMay 19, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
SARS-CoV 2
Sponsor
University of Missouri-Columbia
Enrollment
26
Locations
1
Primary Endpoint
Change in 6 Minute Walk Test
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

This study seeks to assess the impact of physical and pulmonary rehabilitation on patients who have been diagnosed with COVID-19 in the short and long term in hopes of establishing a best practices protocol for treatment of future patients with this disease.

Detailed Description

The novel coronavirus that began in Wuhan, China in late 2019 made an appearance in the United States in January 2020. It is a respiratory disease spreading rapidly from person to person. Recent data shows that fibrosis is seen on the lungs, and possible myocardial damage. Data shows that physical therapy was not highly utilized in recovery for these patients due to high PPE demands, and increased risk of exposure. This study will be using telehealth services to assess and treat these patients so Physical Therapy guidance is provided for movement and returning to prior level of function. Currently there is no data showing the long term effects of the those who were able to utilize Physical Therapy in recovering from COVID-19 This study will be looking at the differences in outcomes of COVID-19 positive subjects who able to complete Physical Therapy Telehealth visits versus those who did not. All groups will be tested at multiple data points for lung capacity, upper and lower extremity strength, and overall endurance to determine the long term functional effects. The control group were diagnosed with COVID-19 and recovered before the Physical and Pulmonary protocol was implemented.

Registry
clinicaltrials.gov
Start Date
May 19, 2020
End Date
September 19, 2020
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Jennifer Y Stone

Manager, Clinical Rehabilitative Services

University of Missouri-Columbia

Eligibility Criteria

Inclusion Criteria

  • \>Age of 18
  • Positive COVID-19 diagnosis in the last 6 months

Exclusion Criteria

  • Age of \<18

Outcomes

Primary Outcomes

Change in 6 Minute Walk Test

Time Frame: From 6 to 24 months post diagnosis

Validated test demonstrating functional gait capacity and endurance; measuring change in capacity over time in 6 month increments.

Change in Short Form 35 (SF-36) Questionnaire

Time Frame: From 6 to 24 months post diagnosis

Validated questionnaire assessing function and quality of life for patients with pulmonary function issues

Secondary Outcomes

  • Change in Peak Flow Meter Test(From 6 to 24 months post diagnosis)
  • Change in Strength testing(From 6 to 24 months post diagnosis)

Study Sites (1)

Loading locations...

Similar Trials